Literature DB >> 12843581

Preparation and evaluation of combination tablet containing incompatible active ingredients.

Xiaoyan Wang1, Fude Cui, Yorinobu Yonezawa, Hisakazu Sunada.   

Abstract

Combination preparation plays an important role in clinical treatment because of its better and wider curative synergism and weaker side effects. However, the existence of incompatibility between active ingredients or between active ingredients and excipients presents a serious obstacle in the preparation of such combination solid dosage forms. In this study, aspirin and ranitidine hydrochloride, between which there existed a chemical interaction, were selected as model drugs. Aspirin powders without any additives were granulated with hydroxypropyl methyl cellulose (HPMC) water solution as a binder using a Wurster coating apparatus and the operation conditions were optimized by Artificial Neural Network (ANN) analysis. Under these conditions, the aspirin granules prepared showed good flowability and compressibility. On the other hand, ranitidine hydrochloride was coated with Aquacoat (ethyl cellulose aqueous dispersion) after preliminary granulation with the Wurster coating apparatus. The aspirin granules and coated ranitidine hydrochloride particles were compressed into tablets with suitable excipients. The combination tablets showed good dissolution, content uniformity and improved stability of active ingredients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12843581     DOI: 10.1248/cpb.51.772

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  2 in total

1.  Stability enhancement of drug layered pellets in a fixed dose combination tablet.

Authors:  Matthew D Burke; Xiaorong He; Chris Cook; Greg A Petrov; Susan Long; Mark D Coffin
Journal:  AAPS PharmSciTech       Date:  2013-01-15       Impact factor: 3.246

2.  Orally Disintegrating Tablet Manufacture via Direct Powder Compression Using Cellulose Nanofiber as a Functional Additive.

Authors:  Shohei Nakamura; Tomomi Fukai; Takatoshi Sakamoto
Journal:  AAPS PharmSciTech       Date:  2021-12-23       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.